Furosemide
- CAS No.
- 54-31-9
- Chemical Name:
- Furosemide
- Synonyms
- FRUSEMIDE;FUROSEMID;fursemide;Furosemide Injection;lasix;salix;4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID;4-chloro-2-((furan-2-ylMethyl)aMino)-5-sulfaMoylbenzoic acid;ERIS;Furix
- CBNumber:
- CB2445739
- Molecular Formula:
- C12H11ClN2O5S
- Molecular Weight:
- 330.74
- MOL File:
- 54-31-9.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/12/18 14:07:02
Melting point | 220 °C (dec.) (lit.) |
---|---|
Boiling point | 582.1±60.0 °C(Predicted) |
Density | 1.606 |
refractive index | 1.6580 (estimate) |
Flash point | 11 °C |
storage temp. | 2-8°C |
solubility | Practically insoluble in water, soluble in acetone, sparingly soluble in ethanol (96 per cent), practically insoluble in methylene chloride. It dissolves in dilute solutions of alkali hydroxides. |
pka | pKa 3.8 (Uncertain) |
form | powder |
color | White to Off-White |
Water Solubility | Soluble in acetone, DMF or methanol. Slightly soluble in water |
Merck | 14,4309 |
BCS Class | 2 (CLogP), 4 (LogP) |
Stability | Stable, but light sensitive, air sensitive and hygroscopic. Incompatible with strong oxidizing agents. |
InChIKey | ZZUFCTLCJUWOSV-UHFFFAOYSA-N |
CAS DataBase Reference | 54-31-9(CAS DataBase Reference) |
IARC | 3 (Vol. 50) 1990 |
EPA Substance Registry System | Furosemide (54-31-9) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07,GHS08 |
---|---|
Signal word | Danger |
Hazard statements | H302-H360FD |
Precautionary statements | P202-P264-P270-P280-P301+P312-P308+P313 |
Hazard Codes | T,F,Xi |
Risk Statements | 61-39/23/24/25-23/24/25-11-36/37/38 |
Safety Statements | 7-16-36/37-45-53-36/37/39-22-36-26 |
RIDADR | UN 1230 3/PG 2 |
WGK Germany | 3 |
RTECS | CB2625000 |
HS Code | 2935904000 |
Hazardous Substances Data | 54-31-9(Hazardous Substances Data) |
Toxicity | LD50 orally in female, male rats: 2600, 2820 mg/kg (Goldenthal) |
Furosemide price More Price(10)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | F4381 | Furosemide | 54-31-9 | 1G | ₹5715.6 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SAB1306550 | ANTI-TM173(C-TERMINAL) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 54-31-9 | 400μL | ₹47796.6 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | F4381 | Furosemide | 54-31-9 | 5G | ₹27019.2 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SAB1306152 | ANTI-TM173(C-TERMINAL) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 54-31-9 | 400μL | ₹47796.6 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | F4381 | Furosemide | 54-31-9 | 10G | ₹31457.45 | 2022-06-14 | Buy |
Furosemide Chemical Properties,Uses,Production
Description
Furosemide (Item No. 26298) is an analytical reference standard categorized as a diuretic. Formulations containing diuretics, including furosemide, have been misused in sports for weight reduction and as masking agents in humans and to prevent exercise-induced pulmonary hemorrhage in racehorses. This product is intended for use in analytical forensic applications. This product is also available as a general research tool .
Chemical Properties
white to light yellow crystal powde
Uses
Furosemide inhibits ion co-transport in the kidney. Furosemide is used as a diuretic.
Definition
A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration and anti-hypertensive agent.
General Description
Odorless white to slightly yellow crystalline powder. A diuretic drug. Almost tasteless.
Air & Water Reactions
Light sensitive. Air sensitive. Slightly soluble in water.
Reactivity Profile
Furosemide may undergo hydrolysis at sufficiently low pH. The pH of aqueous solutions should be maintained in the basic range to prevent hydrolysis. Alcohol has been shown to improve the stability of Furosemide. Incompatible with strong oxidizing agents .
Hazard
Poison; moderately toxic; teratogen; questionable carcinogen; mutagen.
Fire Hazard
Flash point data for Furosemide are not available; however, Furosemide is probably combustible.
Biological Activity
Loop diuretic that inhibits the Na + /2Cl - /K + (NKCC) cotransporter. Also acts as a non-competitive antagonist at GABA A receptors with ~ 100-fold greater selectivity for α 6-containing receptors than α 1-containing receptors.
Mechanism of action
Furosemide is a highly effective and quick-acting diuretic whose action, like all of the examined loop diuretics, is associated with blocking reabsorption of ions in the ascending bend of Henle’s loop. It is used for edema syndrome of various origins, edema of the lungs and brain, chronic renal insufficiency, some forms of hypertonic crises, and poisoning by barbiturates and other compounds excreted mainly with urine.
Clinical Use
Furosemide has a saluretic effect 8- to 10-fold that of the thiazide diuretics; however, it has a shorter duration of action (~6–8 hours). Furosemide causes a marked excretion of sodium, chloride, potassium, calcium, magnesium, and bicarbonate ions, with as much as 25% of the filtered load of sodium excreted in response to initial treatment. It is effective for the treatment of edemas connected with cardiac, hepatic, and renal sites. Because it lowers the blood pressure similar to the thiazide derivatives, one of its uses is in the treatment of hypertension.
Side effects
Clinical toxicity of furosemide and other loop diuretics primarily involves abnormalities of fluid and electrolyte balance. As with the thiazide diuretics, hypokalemia is an important adverse effect that can be prevented or treated with potassium supplements or coadministration of potassium-sparing diuretics. Increased calcium ion excretion can be a problem for postmenopausal osteopenic women, and furosemide generally should not be used in these individuals. Hyperuricemia, glucose intolerance, increased serum lipid levels, ototoxicity, and gastrointestinal side effects might be observed as well. Hypersensitivity reactions also are possible with furosemide (a sulfonamide-based drug), and cross-reactivity with other sulfonamide containing drugs is possible.
Safety Profile
Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Human systemic effects by intravenous route: change in the sensitivity of the ear to sound, tinnitus, unspecified effects on the heart, constriction of the arteries, a decrease in urine volume, interstitial nephritis, metabolic alkalosis, pulse rate decrease, fall in blood pressure. Ingestion can damage the liver. Experimental teratogenic and reproductive effects. Questionable carcinogen with experimental carcinogenic effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of Cl-, NOx, and SOx.
Furosemide Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Jigs Chemical ltd | +919099003427 | Gujarat, India | 239 | 58 | Inquiry |
HEMA PHARMACEUTICALS PVT LTD | +91-9537936912 +91-9537936912 | Gujarat, India | 48 | 58 | Inquiry |
THE MOLECULEZ | +91-7506703683 +91-7506703683 | Maharashtra, India | 79 | 58 | Inquiry |
Hem-Deep Organics Pvt. Ltd. (HOPL) | +91-9998689897 +91-9824114578 | Gujarat, India | 12 | 58 | Inquiry |
Ipca Laboratories Ltd | +91-2262105000 +91-2262105000 | Maharashtra, India | 61 | 58 | Inquiry |
Prachi Pharmaceuticals Pvt Ltd | +919004877711 | Mumbai, India | 36 | 58 | Inquiry |
Macleods Pharmaceuticals Limited | +91-2266762800 +91-2266762800 | Maharashtra, India | 116 | 58 | Inquiry |
Vasoya Industries Pvt Ltd | +91-9898083583 +91-9898083583 | Gujarat, India | 42 | 58 | Inquiry |
Lakshmi Farmachem | +91-9948795885 +91-9550886476 | Telangana, India | 407 | 58 | Inquiry |
Mangalam Drugs and Organics Ltd | +91-2222616300 +91-2222616200 | Maharashtra, India | 37 | 58 | Inquiry |
Related articles
- Furosemide: Mechanism of action, Metabolism, and Pharmacologic effects
- Furosemide is a sulfonamide derivative and is the most commonly used diuretic in the neonate.
- Aug 27,2024
- Side effects of Furosemide
- Furosemide is the diuretic of choice in acute pulmonary oedema or other states of fluid overload (e.g. cardiac, renal or liver....
- Feb 24,2022
54-31-9(Furosemide)Related Search:
1of4
chevron_right